Croda International PLC Unsponsored ADR (OTCMKTS:COIHY) Short Interest Update

Croda International PLC Unsponsored ADR (OTCMKTS:COIHY) was the target of a significant decline in short interest during the month of June. As of June 30th, there was short interest totaling 55 shares, a decline of 97.9% from the June 15th total of 2,576 shares. Based on an average trading volume of 12,409 shares, the days-to-cover ratio is presently 0.0 days. Currently, 0.0% of the company’s stock are sold short.

Croda International Price Performance

Croda International stock traded up $0.32 during midday trading on Friday, hitting $19.44. The stock had a trading volume of 12,886 shares, compared to its average volume of 3,752. The business has a fifty day moving average price of $19.83 and a 200 day moving average price of $19.45. Croda International has a 12 month low of $16.26 and a 12 month high of $22.29. The company has a quick ratio of 1.18, a current ratio of 1.99 and a debt-to-equity ratio of 0.21.

Analyst Upgrades and Downgrades

Several research analysts recently commented on the company. Zacks Research upgraded Croda International from a “strong sell” rating to a “hold” rating in a research note on Monday, June 22nd. Kepler Capital Markets upgraded Croda International from a “reduce” rating to a “hold” rating in a report on Tuesday, March 31st. One analyst has rated the stock with a Strong Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy”.

About Croda International

Croda International plc is a UK-based specialty chemicals company headquartered in East Yorkshire, England. Established in 1925, Croda has built a global reputation for developing and manufacturing high-performance ingredients derived primarily from natural oils and renewable resources. The company’s research-driven approach has enabled it to innovate across a wide range of sectors, delivering solutions that combine efficacy, sustainability and compliance with stringent regulatory standards.

Croda’s operations are organized around three core segments: Personal Care, Life Sciences and Performance Technologies.